Egetis Therapeutics AB (publ) (STO: EGTX)
Sweden
· Delayed Price · Currency is SEK 5.80
-0.09 (-1.53%)
Aug 30, 2024, 5:29 PM CET
Egetis Therapeutics AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Cash & Equivalents | 181.1 | 119.4 | 237.9 | 190.2 | 448 | 40.4 | Upgrade
|
| Cash & Short-Term Investments | 181.1 | 119.4 | 237.9 | 190.2 | 448 | 40.4 | Upgrade
|
| Cash Growth | -3.05% | -49.81% | 25.08% | -57.54% | 1008.91% | 1736.36% | Upgrade
|
| Accounts Receivable | 10.7 | 3.5 | 1.9 | 3.1 | 5.6 | 12.5 | Upgrade
|
| Other Receivables | 31 | 21.3 | 13.9 | 20 | 2.8 | 0.9 | Upgrade
|
| Receivables | 41.7 | 24.8 | 15.8 | 23.1 | 8.4 | 81.7 | Upgrade
|
| Prepaid Expenses | - | 12.7 | 9 | 4.4 | 1.7 | 1.5 | Upgrade
|
| Other Current Assets | -0.1 | -0.1 | 0.9 | 5.7 | - | - | Upgrade
|
| Total Current Assets | 222.7 | 156.8 | 263.6 | 223.4 | 458.1 | 123.6 | Upgrade
|
| Property, Plant & Equipment | 4,690 | 4,420 | 4,316 | 3,999 | 3,322 | 2,440 | Upgrade
|
| Other Intangible Assets | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | - | Upgrade
|
| Other Long-Term Assets | 37.6 | 33.4 | 104.6 | 0.5 | 0.1 | - | Upgrade
|
| Total Assets | 4,950 | 4,611 | 4,684 | 4,223 | 3,780 | 2,564 | Upgrade
|
| Accounts Payable | 7.3 | 10.4 | 19.4 | 11.9 | 16.3 | 55.9 | Upgrade
|
| Accrued Expenses | - | 23 | 15.4 | 5 | 15.2 | - | Upgrade
|
| Current Portion of Long-Term Debt | 55.9 | 116.2 | 234 | - | - | 1,036 | Upgrade
|
| Current Portion of Leases | - | - | - | - | - | 4.5 | Upgrade
|
| Current Income Taxes Payable | - | 0.6 | 1.8 | 4 | 14.6 | - | Upgrade
|
| Current Unearned Revenue | - | 10.2 | 3.1 | 22.5 | 29 | - | Upgrade
|
| Other Current Liabilities | 67.4 | 63.1 | 42.7 | 37.9 | 12 | 37.7 | Upgrade
|
| Total Current Liabilities | 130.6 | 223.5 | 316.4 | 81.3 | 87.1 | 1,134 | Upgrade
|
| Long-Term Debt | 2,052 | 1,919 | 1,654 | 1,720 | 1,458 | 326.7 | Upgrade
|
| Long-Term Leases | - | 1.4 | 1.7 | 1.8 | 88.8 | 86.1 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 161.9 | 157.6 | 195.6 | 139.1 | 86.5 | 61.6 | Upgrade
|
| Other Long-Term Liabilities | 4.2 | 5.5 | 13.7 | 4.5 | 1.6 | - | Upgrade
|
| Total Liabilities | 2,351 | 2,308 | 2,183 | 1,947 | 1,723 | 1,608 | Upgrade
|
| Common Stock | 0.8 | 0.5 | 0.5 | 0.5 | 0.5 | 0.1 | Upgrade
|
| Additional Paid-In Capital | 2,075 | 1,787 | 1,787 | 1,787 | 1,787 | 749.6 | Upgrade
|
| Retained Earnings | 496 | 491.6 | 691.7 | 483.5 | 273.8 | 202 | Upgrade
|
| Comprensive Income & Other | 28 | 23.3 | 22 | 5 | -3.3 | 3.8 | Upgrade
|
| Shareholders' Equity | 2,600 | 2,302 | 2,501 | 2,276 | 2,058 | 955.5 | Upgrade
|
| Total Liabilities & Equity | 4,950 | 4,611 | 4,684 | 4,223 | 3,780 | 2,564 | Upgrade
|
| Total Debt | 2,108 | 2,036 | 1,890 | 1,721 | 1,547 | 1,453 | Upgrade
|
| Net Cash (Debt) | -1,927 | -1,917 | -1,652 | -1,531 | -1,099 | -1,413 | Upgrade
|
| Net Cash Per Share | -29.50 | -32.49 | -28.00 | -25.95 | -18.63 | - | Upgrade
|
| Filing Date Shares Outstanding | 88.49 | 58.99 | 58.99 | 58.99 | 58.99 | 58.99 | Upgrade
|
| Total Common Shares Outstanding | 88.49 | 58.99 | 58.99 | 58.99 | 58.99 | 58.99 | Upgrade
|
| Working Capital | 92.1 | -66.7 | -52.8 | 142.1 | 371 | -1,010 | Upgrade
|
| Book Value Per Share | 29.38 | 39.03 | 42.40 | 38.58 | 34.88 | 16.20 | Upgrade
|
| Tangible Book Value | 2,599 | 2,302 | 2,501 | 2,276 | 2,058 | 955.5 | Upgrade
|
| Tangible Book Value Per Share | 29.38 | 39.02 | 42.40 | 38.58 | 34.88 | 16.20 | Upgrade
|
| Machinery | - | 25.8 | 23.2 | 21.8 | 21.2 | 19.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.